Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis

被引:0
|
作者
Clerico, Marinella [1 ]
Faggiano, Fabrizio [2 ]
Rice, George P. [3 ]
Palace, Jacqueline [4 ]
Tintore, Mar [5 ]
Durelli, Luca [1 ]
机构
[1] Univ Turin, Dipartimento Sci Clin & Biol, Osped San Luigi Gonzaga, Orbassano, TO, Italy
[2] Univ Piemonte Orientale, Novara, Italy
[3] London Hlth Sci Ctr, London, ON, Canada
[4] Radcliffe Infirm, Univ Dept Clin Neurol, Oxford OX2 6HE, England
[5] Hosp Univ Vall Hebron, Unitat Neuroimmunol Clin, Barcelona, Spain
来源
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [1] How to prevent conversion from clinically isolated syndromes to clinically defined multiple sclerosis? A cochrane meta-analysis of published trials
    Clerico, Marinella
    Faggiano, Fabrizio
    Palace, Jacqueline
    Tintore-Subirana, Maria
    Rice, George P.
    Durelli, Luca
    NEUROLOGY, 2008, 70 (11) : A92 - A92
  • [2] Prediction of early conversion to multiple sclerosis in clinically isolated syndrome
    Cinar, B. Piri
    Ozakbas, S.
    Idiman, E.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 59 - 60
  • [3] Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis
    Clerico, M.
    Faggiano, F.
    Subirana, M. Tintore'
    Palace, J.
    Rice, G.
    Durelli, L.
    JOURNAL OF NEUROLOGY, 2008, 255 : 37 - 37
  • [4] Predictive factors of conversion of clinically isolated syndrome to clinically definite multiple sclerosis
    Kolcava, J.
    Vlckova, E.
    Pelisek, O.
    Kocica, J.
    Krkoska, P.
    Bednarik, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 640 - 641
  • [5] Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
    Clerico, M.
    Faggiano, F.
    Palace, J.
    Rice, G.
    Subirana, M. Tintore
    Durelli, L.
    MULTIPLE SCLEROSIS, 2006, 12 : S128 - S128
  • [6] Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study
    Kolcava, Jan
    Kocica, Jan
    Hulova, Monika
    Dusek, Ladislav
    Horakova, Magda
    Kerkovsky, Milos
    Stulik, Jakub
    Dostal, Marek
    Kuhn, Matyas
    Vlckova, Eva
    Bednarik, Josef
    Benesova, Yvonne
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [7] Conversion from clinically isolated syndromes to multiple sclerosis:: how could we prevent it?: A Cochrane review of published trials
    Clerico, M.
    Faggiano, F.
    Rice, G.
    Palace, J.
    Tintore, M.
    Durelli, L.
    MULTIPLE SCLEROSIS, 2007, 13 : S92 - S92
  • [8] Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis
    Arikanoglu, Adalet
    Shugaiv, Erkingul
    Tuzun, Erdern
    Erakso, Mefkure
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (07) : 476 - 479
  • [9] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses
    Comi, Giancarlo
    Carra, Adriana
    Fazekas, Franz
    Rieckmann, Peter
    Bajenaru, O.
    Hillert, Jan
    Elovaara, Irina
    Young, Carolyn
    Wynn, Daniel
    King, John
    Lubetzki, Catherine
    Hartung, Hans-Peter
    Myhr, Kjell-Morten
    Montalban, Xavier
    Komoly, Samuel
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S38 - S38
  • [10] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome suggestive of MS
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 10 - 10